DE3376387D1 - The use of gallium salts for the manufacture of pharmaceutical compositions for the treatment of disorders of calcium homeostasis - Google Patents

The use of gallium salts for the manufacture of pharmaceutical compositions for the treatment of disorders of calcium homeostasis

Info

Publication number
DE3376387D1
DE3376387D1 DE8383110490T DE3376387T DE3376387D1 DE 3376387 D1 DE3376387 D1 DE 3376387D1 DE 8383110490 T DE8383110490 T DE 8383110490T DE 3376387 T DE3376387 T DE 3376387T DE 3376387 D1 DE3376387 D1 DE 3376387D1
Authority
DE
Germany
Prior art keywords
disorders
manufacture
treatment
pharmaceutical compositions
calcium homeostasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383110490T
Other languages
English (en)
Inventor
Raymond P Warrell
Richard Bockman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Memorial Sloan Kettering Cancer Center
Original Assignee
Sloan Kettering Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research filed Critical Sloan Kettering Institute for Cancer Research
Application granted granted Critical
Publication of DE3376387D1 publication Critical patent/DE3376387D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8383110490T 1982-10-22 1983-10-21 The use of gallium salts for the manufacture of pharmaceutical compositions for the treatment of disorders of calcium homeostasis Expired DE3376387D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43613382A 1982-10-22 1982-10-22

Publications (1)

Publication Number Publication Date
DE3376387D1 true DE3376387D1 (en) 1988-06-01

Family

ID=23731240

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383110490T Expired DE3376387D1 (en) 1982-10-22 1983-10-21 The use of gallium salts for the manufacture of pharmaceutical compositions for the treatment of disorders of calcium homeostasis

Country Status (5)

Country Link
US (1) US4529593A (de)
EP (1) EP0109564B1 (de)
JP (1) JPS59205322A (de)
CA (1) CA1219210A (de)
DE (1) DE3376387D1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556564A (en) * 1983-03-14 1985-12-03 Ethyl Corporation Feeding of zeolite A to poultry
US4976971A (en) * 1983-03-14 1990-12-11 Ethyl Corporation Zeolites in poultry nutrition
JPS6112625A (ja) * 1984-06-20 1986-01-21 スローン‐ケツタリング　インステイテユート　フオー　キヤンサー　リサーチ カルシウム恒常性疾患治療用ガリウム塩
US4686104A (en) * 1985-04-30 1987-08-11 Sloan-Kettering Institute For Cancer Research Methods of treating bone disorders
US4704277A (en) * 1985-04-30 1987-11-03 Sloan-Kettering Institute For Cancer Research Methods of treating bone disorders
US5252345A (en) * 1988-02-08 1993-10-12 Ethyl Corporation Zeolite compositions
US5574027A (en) * 1989-11-22 1996-11-12 Bernstein; Lawrence R. Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
US6004951A (en) * 1989-11-22 1999-12-21 Bernstein; Lawrence Richard Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual
US5258376A (en) * 1989-11-22 1993-11-02 Bernstein Lawrence R Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
US5556645A (en) * 1990-01-12 1996-09-17 Bockman; Richard Methods of enhancing wound healing and tissue repair
JP3395904B2 (ja) * 1990-01-12 2003-04-14 ニューヨーク ソサイエティ フォー ザ リリーフ オヴ ザ ラプチャード アンド クリップルド，メインテイニング ザ ホスピタル フォー スペシャル サージェリー 創傷治癒および組織修復を高める方法
US5686116A (en) * 1990-01-12 1997-11-11 New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery Methods of enhancing repair, healing and augmentation of bone implants
WO1991017751A1 (en) * 1990-05-24 1991-11-28 Fujisawa, Inc. Orally administrable gallium compositions and methods of treatment therewith
US5196412A (en) * 1991-03-06 1993-03-23 Johnson Matthey, Inc. Gallium compounds
DE69225484T2 (de) * 1991-07-25 1998-12-10 Philippe Reims Collery Gallium iii komplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
US5763480A (en) * 1994-02-14 1998-06-09 The Jewish Hospital Of St. Louis Inhibitors of cell-medicated disorders
WO1995024203A1 (en) * 1994-03-11 1995-09-14 Von Hoff Daniel D Improvement in treatment of aids-associated non-hodgkin's lymphoma by gallium nitrate
US7404967B2 (en) * 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
US5747482A (en) * 1996-07-30 1998-05-05 Bernstein; Lawrence R. Methods and compositions to inhibit keratinocyte proliferation
GB2365769A (en) 2000-08-18 2002-02-27 Secr Defence Skin preparations containing silicon
US20020160055A1 (en) * 2000-09-18 2002-10-31 Jack Stapleton Methods for treating human immunodeficiency virus infections with gallium compositions
US7081247B2 (en) * 2002-05-20 2006-07-25 Nidaria Technology Ltd. Composition and method for inhibiting polar capsule discharge and protecting a subject from nematocyst sting
US7119217B2 (en) * 2002-09-23 2006-10-10 Genta Incorporated Tri(alkylcarboxylato)gallium (III) products and pharmaceutical compositions containing them
US7354712B2 (en) * 2003-04-30 2008-04-08 Century Technology, Inc. Estrogen receptor alleles that are predictive of increased susceptibility to bone fracture
CA2591515C (en) * 2004-12-29 2010-06-22 Emisphere Technologies, Inc. Pharmaceutical formulations of gallium salts
KR101218854B1 (ko) 2005-11-01 2013-01-09 사이더로믹스, 엘엘씨 갈륨 화합물을 이용한 구강 및 표면 미생물의 성장 제어
WO2008003050A2 (en) * 2006-06-28 2008-01-03 Emisphere Technologies, Inc. Gallium nitrate formulations
EP2099464B1 (de) * 2006-11-09 2016-05-25 BERNSTEIN, Lawrence Richard Lokale verabreichung von galliumzusammensetzungen zur schmerzbehandlung
US20090275654A1 (en) * 2008-04-30 2009-11-05 Genta Incorporated Pharmaceutical Gallium Compositions and Methods
EP2228080A1 (de) 2009-03-03 2010-09-15 Graftys Galliierte Calciumphosphat-Biomaterialien
US8894958B2 (en) * 2009-03-03 2014-11-25 Centre National De La Recherche Scientifique (C.N.R.S.) Galliated calcium phosphate biomaterials
US8623311B2 (en) 2009-03-03 2014-01-07 Graftys Gallium-doped phosphocalcic compounds
EP2228079A1 (de) 2009-03-03 2010-09-15 Graftys Galliumdotierte phosphorcalciumhaltige Verbindungen
CN102665421A (zh) * 2009-03-30 2012-09-12 尼基制药公司 治疗骨质疏松的方法
US9539233B2 (en) 2009-05-04 2017-01-10 Aridis Pharmaceuticals Inc. Gallium formulation for the treatment and prevention of infectious diseases
US8652509B2 (en) * 2009-11-02 2014-02-18 Moshe Rogosnitzky Method of wound hemostasis using liquid gallium nitrate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US59148A (en) * 1866-10-23 Improvement in telegraphic signals
FR2500303A1 (fr) * 1981-02-20 1982-08-27 Meram Lab Le chlorure de gallium, nouveau medicament anti-cancereux

Also Published As

Publication number Publication date
US4529593A (en) 1985-07-16
CA1219210A (en) 1987-03-17
EP0109564B1 (de) 1988-04-27
JPH0261924B2 (de) 1990-12-21
JPS59205322A (ja) 1984-11-20
EP0109564A1 (de) 1984-05-30

Similar Documents

Publication Publication Date Title
DE3376387D1 (en) The use of gallium salts for the manufacture of pharmaceutical compositions for the treatment of disorders of calcium homeostasis
PT77016B (en) Process for the preparation of topical anti-inflammatory compositions containing pyroxycame as active ingredient
DE3377619D1 (en) Compositions for treatment of disease states involving immunological factors
ZA847549B (en) Composition for treatment of animal diarrhoea
PT76780A (en) Process for the preparation of compositions for topical administration
IT8349596A0 (it) Preparato medicinale per la cura dell'ulcera gastroduodenale
DE3173310D1 (en) Pharmaceutical compositions for promoting the healing of wounds
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
DE3163511D1 (en) Preparation of the calcium salt of alpha-hydroxy-gamma-methylmercaptobutyric acid
PT76974B (en) Process for the manufacture of topical compositions useful for reducing sebum secretion
IL68292A0 (en) Pharmaceutical compositions containing dihydropyridines and their use for the treatment of animals
IL85963A0 (en) Pharmaceutical compositions for the prophylaxis or treatment of disorders or diseases of the gastrointestinal tract,comprising antigenic substances
DE3261760D1 (en) Pharmaceutical compositions for the treatment of skin
IL65184A0 (en) Preparation for the treatment of oral diseases,comprising glycyrrhizin
DE3460620D1 (en) Pharmaceutical or veterinary composition for the treatment of ischemic cardiac disorders
GB2162748B (en) Medicinal composition for the treatment or prevention of acne by oral administration
EP0064388A3 (en) Process for the preparation of retard oral pharmaceutical compositions
ZA839437B (en) Substituted azabicycloalkanes,the use thereof,pharmaceutical compositions containing them,and processes for the preparation of these compounds
ES8403487A1 (es) "procedimiento para la preparacion de n-(2-metoxietil)-noroximorfona".
AR230570A1 (es) Procedimiento para la preparacion de nuevas composiciones farmaceuticas antiulcerosas
DE3272384D1 (en) Medicinal composition for the treatment of certain neuroviroses
GB2124488B (en) Agent for the treatment of wounds
GB2123422B (en) Production of compounds for use in semiconductor preparation
ZA844311B (en) Improved compositions for the treatment of psoriasis
PT76389A (en) Process for the preparation of 7-alpha-aminoacyl-3-chlorocepha-losporins having and anti-infections effect and their use for the preparation of pharmaceutical compositions having an anti-infections effect

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Free format text: VOSSIUS, D., DIPL.-CHEM. TAUCHNER, P., DIPL.-CHEM. DR.RER.NAT. RAUH, P., DIPL.-CHEM. DR.RER.NAT. HEUNEMANN, D., DIPL.-PHYS. DR.RER.NAT. HERMANN, G., DIPL.-PHYS. DR.RER.NAT., PAT.-ANWAELTE, 8000 MUENCHEN

8364 No opposition during term of opposition